29
Participants
Start Date
May 25, 2016
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Chemotherapy
Laboratory Biomarker Analysis
Correlative studies
Metastasectomy
Undergo lung metastasectomy
Quality-of-Life Assessment
Ancillary studies
Therapeutic Conventional Surgery
Undergo hepatectomy
M D Anderson Cancer Center, Houston
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER